EADV Podcast

How severe are the psychological implications of having a sexually transmitted infection (STI)?

What are the main socio-economic factors impacting congenital syphilis?

In this second part of a two-episode series on STIs, Prof. Tiplica and Dr. Freedman re-join us to continue their lively discussion and share their insights concerning underdiagnosis, screening, prevention, stigma, increasing disease awareness in STIs and an outlook on what the future might hold in this field.

Read this relevant Free Access commentary, entitled ‘Sexually transmitted infections’ – 30 years later by Prof. Tiplica, published in the JEADV: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17667

Join us as we go through the JEADV Editor's Picks of June 2022:

(1) COVID toes after adenovirus vector-based COVID-19 vaccine

(2) Cases of hair preservation in frontal fibrosing alopecia in men: the watch sign

3) Immuno-regulatory benefits of sodium propionate supplementation in patients with HIV

(4) Is benzyl alcohol a significant contact allergen?

Read the Editor's Picks here:

https://onlinelibrary.wiley.com/doi/10.1111/jdv.18148

Which test is the gold standard in syphilis?

What are the pros and cons of the currently available testing methods?

In this first part of a two-episode series, we welcome Prof. George-Sorin Tiplica moderating the discussion with Dr. Derek Freedman concerning sexually transmitted infections (STIs).

Join us to learn more about the newest diagnostic techniques, disease burden and current treatment landscape.

Read this relevant Free Access commentary, entitled ‘Sexually transmitted infections – 30 years later’ by Prof. Tiplica, published in the JEADV: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17667

In this episode of the EADV Podcast, we meet Dr Bevin Bhoyrul, consultant dermatologist with expertise in hair disorders, who discusses with Dr Sarah Walsh his experience of recognising and managing a little-mentioned hair-loss entity, Fibrosing Alopecia in a Pattern Distribution (FAPD). Dr Bhoyrul shares his top clinical tips for securing the diagnosis, and shares valuable therapeutic pearls. The study which inspired this conversation can be read here:

https://onlinelibrary.wiley.com/doi/10.1111/jdv.17604

Join us as we go through the JEADV Editor's Picks of May 2022:

(1) Overlapping pathogenesis of atopic dermatitis and Covid-19: is monoclonal antibody treatment appropriate?

(2) Is tertiary syphilis on the rise? A rare case from Japan

(3) Acute neurological side effect of Covid-19 vaccination in leprosy

(4) Collateral benefits of a monoclonal antibody treatment for atopic dermatitis

Read the Editor's Picks here:

https://onlinelibrary.wiley.com/doi/10.1111/jdv.18084

How does living with atopic dermatitis impact quality of life? What are the challenges of patient advocacy? How can we address the unmet needs in this patient community? Join us as renowned patient advocate Bernd Arents talks about his drive to bring the patient perspective into every level of research, including the development of guidelines and peer review of scientific publications. Stay tuned to learn about his own experience of living with atopic dermatitis as well as his role at the Dutch Association of People with Atopic Dermatitis and as a Patient Associate Editor of the British Journal of Dermatology.

Join us as we go through the JEADV Editor's Picks of April 2022:

(1) Vaccination safety: a case of self-limiting lichenoid drug eruption after non-mRNA vaccination

Read the Editor's Picks here:

https://onlinelibrary.wiley.com/doi/10.1111/jdv.18011

What is the prevalence of urticaria? How do the pathophysiological mechanisms differ among its chronic and acute subtypes? What is the role of autoreactivity? Are there any comorbidities with atopic diseases and mental health disorders? Join us as Prof. Jan Gutermuth interviews dermatologist, allergologist and renown urticaria expert Prof. Marcus Mauer, diving into the underlying mechanisms and therapeutical options of urticaria.

Summary Join us as we go through the JEADV Editor's Picks of March 2022:

How did the pandemic enrich our knowledge about hair loss? What do we know about COVID-19 skin manifestations in children? Join us as we tackle these questions and dive into the subject of alopecia areata with renown expert Prof. Ramon Grimalt, including current therapeutic landscape, new technologies and consensus recommendations for clinical trials.